APACC 2019 – Presentations

Thursday 27 JuneFriday 28 JuneSaturday 29 June

Thursday - 27/06/2019

 Opening session: Transition to domestic/regional funds 
Chair: Nittaya Phanuphak & Mark Boyd

TMurphy, Eamonn 2019 120x160he UNAIDS perspective
Eamonn Murphy
UNAIDS Asia and the Pacific, Thailand



Vannakit, Ravipa 2019, 120x160Transitioning from international to domestic funding: Experiences in the Asia Pacific
Ravipa Vannakit, RN, MSc
USAID Regional Development Mission for Asia, Thailand



Ishikawa, Naoko 2019 120x160Transitioning to sustainable mechanisms for priority public health programmes in the Western Pacific
Naoko Ishikawa, MD, MSc, PhD
World Health Organization Regional Office for the Western Pacific, the Philippines




  Parallel session 1: Novel treatment strategies 
Chairs: Mark Boyd & Chung Yan Grace Lui

Cahn, Pedro 2016 120x160Novel treatment strategies for LMICs
Pedro Cahn, MD, PhD
Fundacion Huesped, Argentina



Rakhmanina, Natella 2017Turning challenges into opportunities: Preventing and treating HIV infection among adolescents
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
The George Washington University, Children’s National Health System, USA


  Parallel session 2: The real-life facets of PrEP 
Chairs: Jonathan Schapiro & Iskandar Azwa
 Practical perspective of the use of point-of-care testing for supporting the delivery of HIV pre-exposure prophylaxis
(No permission for publication)

Tsz Ho Kwan
 A mathematical model of HIV prevention strategies in Japanese MSM
Stuart Gilmour
 Starting PrEP during acute HIV infection: What is the risk for antiretroviral drug resistance?
Donn Colby
 Factors associated with transitioning from post-exposure prophylaxis to pre-exposure prophylaxis at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: A five-year observational cohort
Tanat Chinbunchorn
 Demographic characteristics and risk behaviors of transgender women using free versus fee-based pre-exposure prophylaxis (PrEP) services in Bangkok, Thailand
Rena Janamnuaysook
  Parallel session 3: What to consider when initiating ART? 
Chairs: Thuy Le & N. Kumarasamy
 A quality improvement learning network approach to the reduction of HIV-related stigma and discrimination in healthcare settings
Bruce Agins
 Trends of genotypic sensitivity scores of HIV-1 in Taiwan: Potential application in the selection of single-tablet antiretroviral regimens
(No permission for publication)

Sui-Yuan Chang
 Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV observational database (TAHOD) of IeDEA Asia-Pacific
Dhanushi Rupasinghe
 Rapid antiretroviral initiation among Thai HIV-infected youth through the national AIDS program in the era of treatment at any CD4
Sirinya Teeraananchai
 Dual therapy with lopinavir/ritonavir plus lamivudine could be a long-term viable alternative for antiretroviral-therapy-naive adults in resource-limited settings: 144-week results from a randomized, open-label, non-inferiority study from China
Linghua Li
 Capacity-building session 1: Preparing for publication in Lancet journals
Richard Henderson & Fan Yang
 Capacity building session 

Friday- 28/06/2019

 Plenary session 2: Progress in HIV Cure/Elimination
Chairs: Charles Boucher & Pedro Cahn

Hsu, Denise 2019 120x160 newIntroduction to HIV persistence on ART
Denise Hsu, BSc, MBBS, PhD
US Military HIV Research Program, Thailand



McMahon, James 2019 120x160Overview of clinical trials for HIV cure
James McMahon, MBBS, FRACP, MPH, PhD
Monash University, Australia



Kroon, Eugene 2019 120Diagnosing and treating acute HIV infection – implications for HIV cure
Eugene Kroon, MD
SEARCH, Thai Red Cross AIDS Research Center, Thailand


  Parallel session 4: Key population empowerment 
Chairs: Nittaya Phanuphak & Danvic Rosadino

Avery, Matthew 2017 120_bewerkt-grijsKey population community engagement
Matthew Avery, MPH
FHI 360, Thailand



Janamnuaysook, Rena 2019 120x160Key pop-led HIV service delivery – Focus on transgenders
Rena Janamnuaysook, MBA
Thai Red Cross AIDS Research Centre, Thailand


 Zhang, Dapeng 2019 120x160 newBlued experience with empowering MSM in the HIV response
(No permission for publication)
Dapeng Zhang, MD, PhD
BlueD, China
  Parallel session 5: New issues and strategies in Hep B and Hep C 
Chairs: Patrick Li & Chien-Ching Hung
 Prognostic factor for natural eradication of acute hepatitis C infection in HIV positive patients
(No permission for publication)
Haruka Uemura
 HCV seroepidemiology among HCV-seronegative, HIV-positive patients in Northern Taiwan: An expanding epidemic
Li-Hsin Su
 Interim analysis of a randomized clinical trial: HBV revaccination among HIV-positive MSM born in the era of neonatal immunization
Yi-Chia Huang
 Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
Sung-Hsi Huang
 HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan
Miao-Hui Huang
  Parallel session 6: Gone with the wind or not? Opportunistic and co-infections
Chairs: Hsi-Hsun Lin & Shinichi Oka
 The relationships between anal intraepithelial neoplasia, oncogenic HPV and microbiota in gay, bisexual, and other men who have sex with men and have HIV infection
Shu-Hsing Cheng
 Incidence, persistence and factors associated with high-risk human papillomavirus infection among male adolescents with perinatally acquired HIV infection in Thailand
Annette H. Sohn
 Paradoxical immune reconstitution inflammatory syndrome associated with Talaromyces marneffei infection among ART-naïve population
Thanh Nguyen Tat
 A prospective study of the Talaromyces marneffei mannoprotein Mp1p enzyme immunoassay for early detection of Talaromyces marneffei infection in patients with advanced HIV disease in Vietnam
Ly Vo Trieu
 The effects of human papillomavirus (HPV) vaccination on the persistence of high-risk HPV infection and abnormal cervical cytology among sexually active female adolescents with and without perinatally acquired HIV
Pradthana Ounchanum
 Capacity-building session 2: Critical reading/bias in clinical research
Matthew Law, Awachana Jiamsakul & Phillip Chan
 Capacity building session 2 
  Parallel session 7: What need to be done to prevent TB and invasive fungal infections?
Chairs: Thuy Le & Thana Khawcharoenporn

Boulware, David 2019 120Prevention of cryptococcosis and other AIDS-related fungal infections: Strategies for the Asia Pacific region
David Boulware, MD, MPH, CTropMed
University of Minnesota, USA



Leung, Chi Chiu 2019 120x160Controversies in management of latent tuberculosis infection in people living with HIV infection in the Asia Pacific region
Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong


  Parallel session 8: HIV testing? The answer is YES, Stupid!
Chairs: Reena Rajasuriar & Saye Khoo
 We are ready! Willingness to pay and preferred delivery point of service for HIV self-testing kits among men who have sex with men and transgender women in Thailand
Siroat Jitijang
 Acceptability and experiences of assisted and unassisted oral fluid testing among men who have sex with men and transgender women in Thailand: Implications to roll out and scale-up
Siroat Jitijang
 Increased HIV testing and case finding targeting young men who have sex with men in Bali through private & government partnership
Hendry Luis
 Unassisted HIV self-testing in Vietnam
Matthew Avery
 Photographic verification of self-reported HIV self-testing results among Chinese men who have sex with men: An interim analysis
Weiming Tang
  Parallel session 9: The challenges in ART retention
Chairs: Linghua Li & Jeremy Ross
 Back to ART (B2A) initiative in Yunnan province, China
Yunfei Lao
 A dual analysis of loss to follow-up for perinatally HIV-infected adolescents receiving combination antiretroviral therapy in Asia
Adam Bartlett
 Differentiated care delivery through Telemedicine for PLHIV in the Philippines
Katerina Leyritana
 Use and outcomes of antiretroviral monotherapy and treatment interruption in perinatally HIV-infected adolescents in Asia
Adam Bartlett
 Debate: Same-day ART should be implemented in HIV treatment programs in the Asia-Pacific
Chairs: Annette Sohn

Azwa, Iskandar 2019, 120x160Pro-standpoint
Iskandar Azwa, MBChB, MRCP, Dip GUM, Dip HIV
University of Malaya, Malaysia


Salvana, Edsel 2017Con-standpoint
Edsel Salvana, MD, DTM&H, FPCP, FIDSA
University of the Philippines Manila, the Philippines


Saturday- 29/06/2019

 Capacity-building session 3: Online clinical management tools
Jonathan Schapiro, Saye Khoo & Tavitiya Sudjaritruk
 Capacity building session 3
  Parallel session 10: Novel diagnostics in STIs 
Chairs: Donn Colby & Man-Po Lee
 Guy, Rebecca 2019 120x160Novel molecular diagnostics to enhance antimicrobial stewardship of sexually transmitted infections in Asia-Pacific
(Not yet available)
Rebecca Guy, PhD
Kirby Institute, UNSW, Australia

Ramautarsing, Reshmie 2019 120x160Minimum STI package in HIV care and prevention for LMIC
Reshmie Ramautarsing, MD, PhD
Thai Red Cross AIDS Research Centre, Thailand


  Parallel session 11: Current knowledge in viral hepatitis 
Chairs: Jurgen Rockstroh & Owen Tak-Yin Tsang
 Revill, Peter 2017Hepatitis B therapy pipeline: How far are we from cure
Peter Revill, PhD
Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Australia
 EpiHung, Chien-Ching 2016 120x160demic of acute HCV: What have we learned?
Chien-Ching Hung, MD, PhD
National Taiwan University Hospital, Taiwan
  Plenary session 3: PrEP - demedicalization
Chairs: Nittaya Phanuphak & Edsel Salvana

Schmidt, Heather-Marie 2019 120x160Provider’s perspective of PrEP demedicalization
Heather Marie Schmidt, BMedSc (Hon), MPH, PhD
UNAIDS, Thailand


 Rosadino, Danvic 2019 120x160Community perspective of demedicalization of PrEP
Danvic Rosadiño
LoveYourself, the Philippines
 Janamnuaysook, Rena 2019 120x160The use of technology to demedicalize PrEP
Rena Janamnuaysook, MBA
Thai Red Cross AIDS Research Centre, Thailand